Arax Advisory Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Buy |
5,537
+60
| +1% | +$9.68K | 0.04% | 268 |
|
|
2025
Q1 | $932K | Buy |
5,477
+1,546
| +39% | +$263K | 0.06% | 195 |
|
|
2024
Q4 | $653K | Buy |
3,931
+286
| +8% | +$47.5K | 0.04% | 237 |
|
|
2024
Q3 | $627K | Buy |
3,645
+492
| +16% | +$84.6K | 0.06% | 163 |
|
|
2024
Q2 | $486K | Buy |
3,153
+216
| +7% | +$33.3K | 0.05% | 200 |
|
|
2024
Q1 | $452K | Buy |
2,937
+1,436
| +96% | +$221K | 0.05% | 193 |
|
|
2023
Q4 | $237K | Buy |
1,501
+1,093
| +268% | +$173K | 0.03% | 267 |
|
|
2023
Q3 | $59.7K | Buy |
408
+193
| +90% | +$28.2K | 0.01% | 428 |
|
|
2023
Q2 | $32.9K | Buy |
215
+53
| +33% | +$8.12K | ﹤0.01% | 514 |
|
|
2023
Q1 | $25.1K | Buy |
162
+147
| +980% | +$22.8K | ﹤0.01% | 549 |
|
|
2022
Q4 | $2.31K | Hold |
15
| – | – | ﹤0.01% | 922 |
|
|
2022
Q3 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 953 |
|